Articles

Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis

San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute;
San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute;
Institute for Biomedical Technologies, National Research Council, Serrate, Italy;
San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute;
San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute;
San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute;
San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute;
CNR-IRGB, Milan Unit and Humanitas Clinical and Research Center - IRCCS, Milano, Italy;
San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute;
San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute;
CRS4, Science and Technology Park Polaris, Pula, Italy;
CRS4, Science and Technology Park Polaris, Pula, Italy;
San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute;
CNR-IRGB, Milan Unit and Humanitas Clinical and Research Center - IRCCS, Milano, Italy;
Immunologie, Hematologie et Rhumatologie Pediatriques, Hopital Necker-Enfants Malades, Paris, France;
Dept of Bone Marrow Transplantation and Cancer Immunotherapy,Hadassah University Hospital,Jerusalem;
Medical University of Lublin, Lublin, Poland;
Department of Pediatric Hematology, Gazi University, School of Medicine, Ankara, Turkey;
Erciyes University, Pediatric Hematology Oncology, Kayseri, Turkey;
Istanbul Health Science University, Kanuni Sultan Suleyman Training and Research Hospital, Turkey;
Hemato-Oncology Unit, Department of Oncology, Pausilipon Hospital, Napoli, italy;
DIMET, University of Milano-Bicocca, Monza, Italy;
San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute;
Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy;
Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy;
Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
CNR-IRGB, Milan Unit and Humanitas Clinical and Research Center - IRCCS, Milano, Italy;
CNR-IRGB, Milan Unit and Humanitas Clinical and Research Center - IRCCS, Milano, Italy;
San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute;
San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute;
Haematologica Early view Jan 16, 2020 https://doi.org/10.3324/haematol.2019.238261